Literature DB >> 29522650

Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials.

Rebecca A Packer1, John H Rossmeisl2, Michael S Kent3, John F Griffin4, Christina Mazcko5, Amy K LeBlanc5.   

Abstract

The National Cancer Institute Comparative Brain Tumor Consortium, Patient Outcomes Working Group, propose a consensus document in support of standardized magnetic resonance imaging protocols for canine brain tumor clinical trials. The intent of this manuscript is to address the widely acknowledged need to ensure canine brain tumor imaging protocols are relevant and have sufficient equivalency to translate to human studies such that: (1) multi-institutional studies can be performed with minimal inter-institutional variation, and (2) imaging protocols are consistent with human consensus recommendations to permit reliable translation of imaging data to human clinical trials. Consensus recommendations include pre- and postcontrast three-dimensional T1-weighted images, T2-weighted turbo spin echo in all three planes, T2*-weighted gradient recalled echo, T2-weighted fluid attenuated inversion recovery, and diffusion weighted imaging/diffusion tensor imaging in transverse plane; field of view of ≤150 mm; slice thickness of ≤2 mm, matrix ≥ 256 for two-dimensional images, and 150 or 256 for three-dimensional images.
© 2018 American College of Veterinary Radiology.

Entities:  

Keywords:  brain; clinical trials; consensus; magnetic resonance imaging; tumors

Mesh:

Year:  2018        PMID: 29522650      PMCID: PMC5942214          DOI: 10.1111/vru.12608

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  92 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 2.  Defining the Value of a Comparative Approach to Cancer Drug Development.

Authors:  Amy K LeBlanc; Christina N Mazcko; Chand Khanna
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

3.  Brain lesion contrast in MR imaging. Dependence on field strength and concentration of gadodiamide injection in patients and phantoms.

Authors:  P Akeson; B Vikhoff; F Ståhlberg; S Holtås
Journal:  Acta Radiol       Date:  1997-01       Impact factor: 1.990

4.  Whole-brain intracranial vessel wall imaging at 3 Tesla using cerebrospinal fluid-attenuated T1-weighted 3D turbo spin echo.

Authors:  Zhaoyang Fan; Qi Yang; Zixin Deng; Yuxia Li; Xiaoming Bi; Shlee Song; Debiao Li
Journal:  Magn Reson Med       Date:  2016-02-28       Impact factor: 4.668

5.  Diffusion-weighted magnetic resonance imaging of the normal canine brain.

Authors:  Antje Hartmann; Charlotte Söffler; Klaus Failing; Andreas Schaubmar; Martin Kramer; Martin J Schmidt
Journal:  Vet Radiol Ultrasound       Date:  2014-05-02       Impact factor: 1.363

Review 6.  Imaging of the post-operative cranium.

Authors:  Audrey G Sinclair; Daniel J Scoffings
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

7.  Reversible magnetic resonance imaging abnormalities in dogs following seizures.

Authors:  L M Mellema; P D Koblik; G D Kortz; R A LeCouteur; M A Chechowitz; P J Dickinson
Journal:  Vet Radiol Ultrasound       Date:  1999 Nov-Dec       Impact factor: 1.363

Review 8.  Response Assessment in Neuro-Oncology Clinical Trials.

Authors:  Patrick Y Wen; Susan M Chang; Martin J Van den Bent; Michael A Vogelbaum; David R Macdonald; Eudocia Q Lee
Journal:  J Clin Oncol       Date:  2017-06-22       Impact factor: 44.544

9.  Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.

Authors:  S M Nguyen; D H Thamm; D M Vail; C A London
Journal:  Vet Comp Oncol       Date:  2013-03-28       Impact factor: 2.613

10.  Appearance of the canine meninges in subtraction magnetic resonance images.

Authors:  Christopher R Lamb; Richard Lam; Erin K Keenihan; Stephen Frean
Journal:  Vet Radiol Ultrasound       Date:  2014-05-16       Impact factor: 1.363

View more
  10 in total

1.  Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial.

Authors:  Hamed Arami; Chirag B Patel; Steven J Madsen; Peter J Dickinson; Ryan M Davis; Yitian Zeng; Beverly K Sturges; Kevin D Woolard; Frezghi G Habte; Demir Akin; Robert Sinclair; Sanjiv S Gambhir
Journal:  ACS Nano       Date:  2019-02-04       Impact factor: 15.881

2.  Three-dimensional T1-weighted gradient echo is a suitable alternative to two-dimensional T1-weighted spin echo for imaging the canine brain.

Authors:  Kathryn L Fleming; Thomas W Maddox; Christopher M R Warren-Smith
Journal:  Vet Radiol Ultrasound       Date:  2019-05-30       Impact factor: 1.363

Review 3.  Companion animal models of neurological disease.

Authors:  Brittanie Partridge; John H Rossmeisl
Journal:  J Neurosci Methods       Date:  2019-11-13       Impact factor: 2.390

Review 4.  Neuroimaging in Randomized, Multi-Center Clinical Trials of Endovascular Treatment for Acute Ischemic Stroke: A Systematic Review.

Authors:  Chong Hyun Suh; Seung Chai Jung; Byungjun Kim; Se Jin Cho; Dong Cheol Woo; Woo Yong Oh; Jong Gu Lee; Kyung Won Kim
Journal:  Korean J Radiol       Date:  2020-01       Impact factor: 3.500

5.  Patterns of local residual disease and local failure after intensity modulated/image guided radiation therapy for sinonasal tumors in dogs.

Authors:  Valerie J Poirier; Ethel S Y Koh; Johnson Darko; Andre Fleck; Christopher Pinard; David M Vail
Journal:  J Vet Intern Med       Date:  2021-03-04       Impact factor: 3.333

6.  Comparison of linear and volumetric criteria for the determination of therapeutic response in dogs with intracranial gliomas.

Authors:  Josefa Karina Garcia Mora; John Robertson; Fang-Chi Hsu; Richard Levon Shinn; Martha M Larson; Christopher G Rylander; Christopher T Whitlow; Waldemar Debinski; Rafael V Davalos; Gregory B Daniel; John H Rossmeisl
Journal:  J Vet Intern Med       Date:  2022-03-11       Impact factor: 3.175

7.  Comparison of direct measurement of intracranial pressures and presumptive clinical and magnetic resonance imaging indicators of intracranial hypertension in dogs with brain tumors.

Authors:  Savannah Giannasi; Yukitaka Kani; Fang-Chi Hsu; John H Rossmeisl
Journal:  J Vet Intern Med       Date:  2020-05-16       Impact factor: 3.333

8.  Advanced Cancer Imaging Applied in the Comparative Setting.

Authors:  David M Vail; Amy K LeBlanc; Robert Jeraj
Journal:  Front Oncol       Date:  2020-02-07       Impact factor: 6.244

9.  Risk factors for adverse events occurring after recovery from stereotactic brain biopsy in dogs with primary intracranial neoplasia.

Authors:  Richard L Shinn; Yukitaka Kani; Fang-Chi Hsu; John H Rossmeisl
Journal:  J Vet Intern Med       Date:  2020-09-14       Impact factor: 3.333

10.  Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.

Authors:  John H Rossmeisl; Denise Herpai; Mindy Quigley; Thomas E Cecere; John L Robertson; Ralph B D'Agostino; Jonathan Hinckley; Stephen B Tatter; Peter J Dickinson; Waldemar Debinski
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.